IRIS Accounts Production v26.3.0.614 16811162 Board of Directors 31.3.26 27.10.25 31.3.26 31.3.26 537 true true true false true true false false false false false false false false false false false true false Preference 0 0 Ordinary 0 Preference 0 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh168111622025-10-26168111622026-03-31168111622025-10-272026-03-31168111622025-10-2616811162ns15:EnglandWales2025-10-272026-03-3116811162ns14:PoundSterling2025-10-272026-03-3116811162ns10:Director12025-10-272026-03-3116811162ns10:Consolidated2026-03-3116811162ns10:ConsolidatedGroupCompanyAccounts2025-10-272026-03-3116811162ns10:PrivateLimitedCompanyLtd2025-10-272026-03-3116811162ns10:FRS102ns10:Consolidated2025-10-272026-03-3116811162ns10:Consolidatedns10:Audited2025-10-272026-03-3116811162ns10:SmallCompaniesRegimeForDirectorsReport2025-10-272026-03-3116811162ns10:SmallCompaniesRegimeForAccounts2025-10-272026-03-3116811162ns10:Consolidatedns10:LargeCompaniesRegimeForDirectorsReport2025-10-272026-03-3116811162ns10:Consolidatedns10:LargeCompaniesRegimeForAccounts2025-10-272026-03-3116811162ns10:FullAccounts2025-10-272026-03-3116811162ns5:Subsidiary12025-10-272026-03-3116811162ns5:Subsidiary22025-10-272026-03-3116811162ns5:Subsidiary32025-10-272026-03-3116811162ns5:Subsidiary42025-10-272026-03-3116811162ns5:Subsidiary52025-10-272026-03-3116811162ns5:Subsidiary62025-10-272026-03-3116811162ns5:Subsidiary72025-10-272026-03-3116811162ns5:Subsidiary82025-10-272026-03-311681116212025-10-272026-03-3116811162ns10:PreferenceShareClass32025-10-272026-03-31168111628ns10:PreferenceShareClass32025-10-272026-03-3116811162ns10:OrdinaryShareClass12025-10-272026-03-3116811162ns10:OrdinaryShareClass22025-10-272026-03-31168111621ns10:OrdinaryShareClass12025-10-272026-03-3116811162ns10:OrdinaryShareClass222025-10-272026-03-3116811162ns10:Consolidated2025-10-272026-03-3116811162ns10:Director22025-10-272026-03-3116811162ns10:Director32025-10-272026-03-3116811162ns10:Director42025-10-272026-03-3116811162ns10:Director52025-10-272026-03-3116811162ns10:Director62025-10-272026-03-3116811162ns10:Director72025-10-272026-03-3116811162ns10:RegisteredOffice2025-10-272026-03-3116811162ns5:CurrentFinancialInstruments2026-03-3116811162ns5:Non-currentFinancialInstruments2026-03-3116811162ns5:ShareCapital2026-03-3116811162ns5:RetainedEarningsAccumulatedLosses2026-03-3116811162ns5:ShareCapital2025-10-272026-03-3116811162ns5:RetainedEarningsAccumulatedLosses2025-10-272026-03-3116811162ns5:NetGoodwill2025-10-272026-03-3116811162ns5:IntangibleAssetsOtherThanGoodwill2025-10-272026-03-3116811162ns5:ComputerSoftware2025-10-272026-03-3116811162ns5:ShortLeaseholdAssetsns5:LandBuildings2025-10-272026-03-3116811162ns5:FurnitureFittings2025-10-272026-03-3116811162ns5:MotorVehicles2025-10-272026-03-3116811162ns5:AdditionsToInvestments2026-03-3116811162ns5:CostValuation2026-03-31168111621ns5:Subsidiary12025-10-272026-03-31168111622ns5:Subsidiary12025-10-272026-03-3116811162ns5:Subsidiary232025-10-272026-03-31168111624ns5:Subsidiary22025-10-272026-03-31168111625ns5:Subsidiary32025-10-272026-03-3116811162ns5:Subsidiary362025-10-272026-03-3116811162ns5:Subsidiary472025-10-272026-03-31168111628ns5:Subsidiary42025-10-272026-03-31168111629ns5:Subsidiary52025-10-272026-03-3116811162ns5:Subsidiary5102025-10-272026-03-3116811162ns5:Subsidiary6112025-10-272026-03-311681116212ns5:Subsidiary62025-10-272026-03-311681116213ns5:Subsidiary72025-10-272026-03-311681116214ns5:Subsidiary72025-10-272026-03-3116811162ns5:Subsidiary8152025-10-272026-03-3116811162ns5:Subsidiary8162025-10-272026-03-3116811162ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3116811162ns10:PreferenceShareClass32026-03-3116811162ns10:OrdinaryShareClass12026-03-3116811162ns10:OrdinaryShareClass22026-03-31
REGISTERED NUMBER: 16811162 (England and Wales)















GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE PERIOD

27 OCTOBER 2025 TO 31 MARCH 2026

FOR

H CARE 2025 LIMITED

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026










Page

Company Information 1

Group Strategic Report 2

Report of the Directors 5

Report of the Independent Auditor 8

Consolidated Income Statement 12

Consolidated Other Comprehensive Income 13

Consolidated Balance Sheet 14

Company Balance Sheet 15

Consolidated Statement of Changes in Equity 16

Company Statement of Changes in Equity 17

Consolidated Cash Flow Statement 18

Notes to the Consolidated Cash Flow Statement 19

Notes to the Consolidated Financial Statements 20


H CARE 2025 LIMITED

COMPANY INFORMATION
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026







DIRECTORS: P A de Savary
H J de Savary
A M de Savary
Ms J Hurley
Mr A F Rosenbach
H S Greene
M A Quantock Shuldham





REGISTERED OFFICE: 55 Loudoun Road
London
NW8 0DL





REGISTERED NUMBER: 16811162 (England and Wales)





AUDITOR: mgr Audit Limited
Chartered Accountants
Statutory Auditors
55 Loudoun Road
St John's Wood
London
NW8 0DL

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

GROUP STRATEGIC REPORT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


The directors present their strategic report of the company and the group for the period 27 October 2025 to 31 March 2026.

REVIEW OF BUSINESS
The accounts reflect the trading performance from the acquisition date of 25th November 2025 and have been prepared in accordance with UK GAAP and company law. However, to give a better understanding of trading performance, Home From Home Care Limited will form the basis of the numbers of the strategic review, being the principal trading entity in the group.

Home From Home Care Limited's turnover from its business increased by 9.0% (2025: 4.5%) in the year with the average occupancy of beds/ apartments at 98% (which was in line with the previous year (2025: 98%)).

Home From Home Care Limited's staff wages increased by 13% reflecting the need to invest in increasing pay rates in response to a very competitive and shifting labour market and the increasing complexity of new placements. During the year the minimum hourly rate was increased to £12.60 per hour, 39p above the April 2025 National Minimum Wage, with the company continuing to pay the Real Living Wage. Throughout the period, the company used no agency staff.

During the year:

- Development commenced in a related party entity, Housing Thirty Five Limited on a new 4 bedded Supported Living service, with completion of the accommodation scheduled for October 2026.
- Turnover increased largely resulting from inflationary increases, and higher fees for more complex Individuals.

Our focus remains on delivering specialist services for individuals with the highest acuity needs who are difficult to place as few providers can meet their exacting needs and manage the increased risk. Operationally, these niche services rely on our unique data informed care model which underpins care delivery and influences the development of our operational structure with associated cost implications.

Direct costs for Home From Home Care Limited increased by 8% (2025: 0.2% decrease) during the year reflecting the above. These increases peaked during the financial year as the company's operational model became more complete.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors consider the main risks faced by the business are:

- Those relating to the provision of substandard care. The directors are aware of these risks and continue the development of its sophisticated care planning and recording systems to ensure that the group's care users receive the best quality care, while keeping fully up to date with current and proposed legislation and regulations, together with enhanced Business Continuity planning.
- The risks associated with the Care Quality Commission and specifically the group's ongoing legal challenge in the Administrative Court around legal matters relating to inspections.
- The political landscape and financial pressures on Councils and ICBs. This is making it increasingly necessary to challenge in order to obtain the required fees to maintain the same level of care for individuals in our service due to inflationary cost pressures.
- The impact of legislation regarding foreign employees and visas for retention of staff.


H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

GROUP STRATEGIC REPORT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

DEVELOPMENT AND PERFORMANCE
The directors continue with the conscious decision to increase investment beyond what would normally be expected in recognition of market challenges, continuing the resetting of its services in line with the risks and opportunities it faced. They are encouraged by the actions taken in the face of continued inflation and the significant increases in the NLW, which have increased pressures on funding, as well as the persistently tight employment market which has shown some signs of improvement due to overseas recruitment. They believe that over an extended period, this strategy will secure the group's sustainability.

POSITION OF THE GROUP AT THE YEAR END
In the opinion of the directors, the group is in a strong position at the year end with shareholders' fund at £627k.

KEY PERFORMANCE INDICATORS
The group's management continually monitors the performance of the homes with particular regard to the quality of the care provision.

Home From Home Care Limited is rated Platinum by Investors in People, whilst 7 of its 11 residential services are rated Outstanding and 3 are rated Good by the Care Quality Commission. The rating of one home was previously the subject of a legal challenge with the Care Quality Commission, with the current legal action relating to issues associated with inspections.

In addition, the group reviews monthly management information including management accounts, occupancy ratios and staffing requirements. The main key financial performance indicators are sales growth referred to above and the operating profit margin which was 6.7% (2025: 2.2%).


H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

GROUP STRATEGIC REPORT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

DUTY TO PROMOTE THE SUCCESS OF THE COMPANY AND EMPLOYEE ENGAGEMENT
During the period, the directors have built on their strategy of supporting individuals with higher acuity and more complex needs. Underpinning the operations of its specialist services is "Zone Standard" the group's single-entry IT platform. Zone Standard provides real time data allowing the group to better manage risk, increasing information available to care home managers, giving them greater insight.

This strategy is building sustainability both for the individuals the group supports and for the longer-term prospects for the group through the increasing effectiveness of data, management, staff teams, specialist teams and highly personalised environments, together comprising the group's groundbreaking data informed care model. This is significantly enhanced by embracing artificial intelligence (AI) and has led to the development of EHI (Enhanced Human Intelligence) which leverages off the Zone Standard platform. This remains a key focus in financial year 2027 and will enable growth and increased support for employees in an increasingly complex environment.

The directors have regard to relationships with employees, the individuals being supported, their families and all key business stakeholders. The individuals are supported to engage with the wider community which in turn supports the local economies, enhancing the group's overall social impact.

Relationships and engagement with staff are fostered through regular direct meetings and communications, with multiple channels for staff to engage with managers and the directors. Regular updates ensure that staff are recognised and our values-based recruitment processes actively encourage progression opportunities, supported by ongoing training and mentoring.

ON BEHALF OF THE BOARD:





H S Greene - Director


30 September 2026

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

REPORT OF THE DIRECTORS
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


The directors present their report with the financial statements of the company and the group for the period 27 October 2025 to 31 March 2026.

INCORPORATION
The group was incorporated on 27 October 2025 .

PRINCIPAL ACTIVITY
The principal activity of the group is the provision and operation of care homes for adults 18+ with learning disabilities and high acuity needs, including autism, epilepsy, complex health and mental health, the provision of personnel and the provision of building services.

DIVIDENDS
No dividends will be distributed for the period ended 31 March 2026.

DIRECTORS
The directors during the period under review were:

P A de Savary - appointed 25.11.2025
H J de Savary - appointed 27.10.2025
A M de Savary - appointed 25.11.2025
J Hurley - appointed 25.11.2025
A F Rosenbach - appointed 25.11.2025
H S Greene - appointed 23.01.2026
M A Quantock Shuldham - appointed 25.11.2025

MARKET VALUE OF LAND AND BUILDINGS
The group's care homes were valued at the period end by the directors at their current market value as reflected in the consolidated accounts.

DISABLED PERSONS
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitude of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the group continues, that reasonable adjustments are made and that the appropriate training is arranged. It is the policy of the group that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

EMPLOYEE INVOLVEMENT
The group's policy is to consult and discuss with employees matters likely to affect their interests. This is achieved amongst other things through survey's staff meetings and one2ones.

Information relating to financial and economic matters is additionally disseminated to employees using information bulletins and reports which seek to achieve a common awareness on the part of all employees of those factors affecting the group's performance.

STREAMLINED ENERGY AND CARBON REPORTING
The assessment has been verified by a third-party (Antea Group) and carried out in accordance with ISO14064-1:2018 Greenhouse Gases - Part 1: Specification with guidance at the organization level for quantification and reporting of greenhouse gas emissions and removals.

The information below sets out total energy consumption and resulting GHG emissions by Scope arising from business operations.




H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

REPORT OF THE DIRECTORS
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


tCO2e
Scope 1 - Heating Fuels 88.74
Scope 1 - Company Vehicles 65.01
Scope 2 - Purchased Electricity 39.11
Scope 3 - Employee Mileage 28.15
Total 221.01

Intensity Ratios
kgCO2e/m2/year 51.05
tCO2e/employee/year 1.53
tCO2e/£m/year 21.09

H Care 2025 Limited is committed to delivering the highest level of care for individuals with learning disabilities whilst also reducing its environmental impact.

In the period the group has utilised renewable electricity tariffs, ensuring that we procure energy from cleaner and renewable sources.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures disclosed
and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditor is unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditor is aware of that information.

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

REPORT OF THE DIRECTORS
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


AUDITOR
The auditors, mgr Audit Limited, are deemed to be reappointed under Section 487(2) of the Companies Act 2006.

ON BEHALF OF THE BOARD:





H S Greene - Director


30 September 2026

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
H CARE 2025 LIMITED


Opinion
We have audited the financial statements of H Care 2025 Limited (the 'parent company') and its subsidiaries (the 'group') for the period ended 31 March 2026 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2026 and of the group's loss for the period then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditor thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
H CARE 2025 LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
H CARE 2025 LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditor that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

As part of our planning of the audit work required we obtained an understanding of the legal and regulatory frameworks that are applicable to the entity via enquiries of the company's management, carried out analytical procedures, held discussions amongst the engagement team and using knowledge of the sector determined that the most significant laws and regulation are those that relate to:

- The regulation of Health and Social Care.
- Health and safety regulations.
- Employment law including right to work in the UK and Disclosure and Barring Service (DBS).
- Medicine Regulation.
- Mental Capacity Act.
- Food Safety Act.
- Environmental protection and waste disposal.
- Fire safety regulations.
- Data Protection.
- Modern Slavery Act.
- UK Tax legislation.

We also considered those laws and regulations that have a direct impact on the preparation of the financial statements such as FRS102 and the Companies Act 2006.

Based on the results of our risk assessment we designed our audit procedures to identify non-compliance with the laws and regulations and the fraud risks identified. This included enquiries with management to understand their policies and procedures for compliance with those regulations and we completed the following tests:

- Obtained an understanding of relevant controls.
- Reviewed the company's risk assessments, procedures and systems.
- Checked samples of documentation including minutes of the meetings of the directors, service agreements with regulatory advisors and reports by the Care Quality commission,the regulator

We also assessed the risks of material misstatement in respect of fraud as follows:
- Revenue fraud.
- Unauthorised expenditure and/or payments.
- Management override of controls.
- Manipulation of accounting estimates.
- Related party fraud.

Based on the results of our risk assessment we designed our audit procedures to identify and to address material misstatements in relation to fraud. This included the risk of management bias relating to judgements and assumptions used in the valuing the leasehold properties and the reporting of the loan covenants.

No significant issues were identified during our testing.


REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF
H CARE 2025 LIMITED

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditor.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditor and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Nigel Walfisz FCA (Senior Statutory Auditor)
for and on behalf of mgr Audit Limited
Chartered Accountants
Statutory Auditors
55 Loudoun Road
St John's Wood
London
NW8 0DL

30 September 2026

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONSOLIDATED INCOME STATEMENT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

Notes £   

TURNOVER 10,583,698

Cost of sales (8,639,430 )
GROSS PROFIT 1,944,268

Administrative expenses (4,043,013 )
(2,098,745 )

Other operating income 15,000
OPERATING LOSS 4 (2,083,745 )

Interest receivable and similar income
Group 201
Associates 210,508
(1,873,036 )

Interest payable and similar expenses 6 (1,364,135 )
LOSS BEFORE TAXATION (3,237,171 )

Tax on loss 7 (327,810 )
LOSS FOR THE FINANCIAL PERIOD (3,564,981 )
Loss attributable to:
Owners of the parent (3,564,981 )

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONSOLIDATED OTHER COMPREHENSIVE INCOME
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

Notes £   

LOSS FOR THE PERIOD (3,564,981 )


OTHER COMPREHENSIVE INCOME
Revaluation of tangible fixed assets 540,937
Income tax relating to other comprehensive
income

(135,234

)
OTHER COMPREHENSIVE INCOME FOR THE
PERIOD, NET OF INCOME TAX

405,703
TOTAL COMPREHENSIVE INCOME FOR THE
PERIOD

(3,159,278

)

Total comprehensive income attributable to:
Owners of the parent (3,159,278 )

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONSOLIDATED BALANCE SHEET
31 MARCH 2026

Notes £    £   
FIXED ASSETS
Intangible assets 9 21,520,672
Tangible assets 10 36,785,578
Investments 11 1,571
58,307,821

CURRENT ASSETS
Debtors 12 5,782,289
Cash at bank and in hand 2,744,115
8,526,404
CREDITORS
Amounts falling due within one year 13 5,146,569
NET CURRENT ASSETS 3,379,835
TOTAL ASSETS LESS CURRENT LIABILITIES 61,687,656

CREDITORS
Amounts falling due after more than one
year

14

(57,620,531

)

PROVISIONS FOR LIABILITIES 17 (3,440,237 )
NET ASSETS 626,888

CAPITAL AND RESERVES
Called up share capital 18 3,786,166
Revaluation reserve 405,703
Retained earnings (3,564,981 )
SHAREHOLDERS' FUNDS 626,888

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2026 and were signed on its behalf by:





H S Greene - Director


H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

COMPANY BALANCE SHEET
31 MARCH 2026

Notes £    £   
FIXED ASSETS
Intangible assets 9 -
Tangible assets 10 -
Investments 11 40,200,015
40,200,015

CURRENT ASSETS
Debtors 12 166,751

CREDITORS
Amounts falling due within one year 13 908,593
NET CURRENT LIABILITIES (741,842 )
TOTAL ASSETS LESS CURRENT LIABILITIES 39,458,173

CREDITORS
Amounts falling due after more than one
year

14

36,913,834
NET ASSETS 2,544,339

CAPITAL AND RESERVES
Called up share capital 18 3,786,166
Retained earnings (1,241,827 )
SHAREHOLDERS' FUNDS 2,544,339

Company's loss for the financial year (1,241,827 )

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2026 and were signed on its behalf by:





H S Greene - Director


H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   

Changes in equity
Issue of share capital 3,786,166 - - 3,786,166
Total comprehensive income - (3,564,981 ) 405,703 (3,159,278 )
Balance at 31 March 2026 3,786,166 (3,564,981 ) 405,703 626,888

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

Called up
share Retained Total
capital earnings equity
£    £    £   

Changes in equity
Issue of share capital 3,786,166 - 3,786,166
Total comprehensive income - (1,241,827 ) (1,241,827 )
Balance at 31 March 2026 3,786,166 (1,241,827 ) 2,544,339

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

CONSOLIDATED CASH FLOW STATEMENT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026

Notes £   
Cash flows from operating activities
Cash generated from operations 1 (2,548,924 )
Interest paid (258,613 )
Interest element of finance lease payments
paid

(326,356

)
Net cash from operating activities (3,133,893 )

Cash flows from investing activities
Purchase of tangible fixed assets (357,316 )
Acquisition of group (40,200,015 )
Cash and cash equivalents acquired 5,735,138
Interest received 201
Net cash from investing activities (34,821,992 )

Cash flows from financing activities
New loans in year 8,700,000
Share issue 3,786,166
Proceeds from preference shares 28,213,834
Net cash from financing activities 40,700,000

Increase in cash and cash equivalents 2,744,115
Cash and cash equivalents at beginning of
period

2

-

Cash and cash equivalents at end of period 2 2,744,115

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


1. RECONCILIATION OF LOSS BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

£   
Loss before taxation (3,237,171 )
Depreciation charges 821,014
Finance costs 1,364,135
Finance income (210,709 )
(1,262,731 )
Increase in trade and other debtors (5,782,288 )
Increase in trade and other creditors 4,496,095
Cash generated from operations (2,548,924 )

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Period ended 31 March 2026
31.3.26 27.10.25
£    £   
Cash and cash equivalents 2,744,115 -


3. ANALYSIS OF CHANGES IN NET DEBT

At 27.10.25 Cash flow At 31.3.26
£    £    £   
Net cash
Cash at bank and in hand - 2,744,115 2,744,115
- 2,744,115 2,744,115
Debt
Finance leases - (21,357,049 ) (21,357,049 )
Debts falling due after 1 year - (36,913,834 ) (36,913,834 )
- (58,270,883 ) (58,270,883 )
Total - (55,526,768 ) (55,526,768 )

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


1. STATUTORY INFORMATION

H Care 2025 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Basis of consolidation
Investments in subsidiaries are accounted for at cost less impairment.

The consolidated financial statements incorporate those of H Care 2025 and all of its subsidiaries (i.e. entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits).

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of the H Care Group in 2025, is being amortised evenly over its estimated useful life of 10 years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software has been fully amortised in the current year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Short leasehold - Nil
Fixtures and fittings - 20% - 33% straight line
Motor vehicles - 25% straight line

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


2. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was as follows:
Care 510
Admin 27
537

£
Directors' remuneration 739,858

Information regarding the highest paid director is as follows:
£
Emoluments 119,604

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


4. OPERATING LOSS

The operating loss is stated after charging:

£   
Hire of plant and machinery 127,218
Depreciation - owned assets 52,296
Goodwill amortisation 769,468
Computer software amortisation 215

5. AUDITORS' REMUNERATION
£   
Fees payable to the company's auditor for the audit of the company's
financial statements

124,481

6. INTEREST PAYABLE AND SIMILAR EXPENSES

£
Bank loan interest 258,613
Leasing 326,356
Preference share dividend 779,166
1,364,135

7. TAXATION

Analysis of the tax charge
The tax charge on the loss for the period was as follows:
£   
Deferred tax 327,810
Tax on loss 327,810

Reconciliation of total tax charge included in profit and loss
The tax assessed for the period is higher than the standard rate of corporation tax in the UK. The difference is explained below:

£   
Loss before tax (3,237,171 )
Loss multiplied by the standard rate of corporation tax in the UK of 25 % (809,293 )

Effects of:
Expenses not deductible for tax purposes 387,158
Utilisation of tax losses 422,135
Deferred tax on timing differences 57,140
Deferred tax on losses 270,670
Total tax charge 327,810

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


7. TAXATION - continued

Tax effects relating to effects of other comprehensive income

Gross Tax Net
£    £    £   
Revaluation of tangible fixed assets 540,937 (135,234 ) 405,703

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


9. INTANGIBLE FIXED ASSETS

Group
Computer
Goodwill software Totals
£    £    £   
COST
Additions 22,290,140 215 22,290,355
At 31 March 2026 22,290,140 215 22,290,355
AMORTISATION
Amortisation for period 769,468 215 769,683
At 31 March 2026 769,468 215 769,683
NET BOOK VALUE
At 31 March 2026 21,520,672 - 21,520,672

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


10. TANGIBLE FIXED ASSETS

Group
Fixtures
Short and Motor
leasehold fittings vehicles Totals
£    £    £    £   
COST OR VALUATION
At 27 October 2025 751 - - 751
Additions 35,899,870 39,000 357,316 36,296,186
Revaluations 540,937 - - 540,937
At 31 March 2026 36,441,558 39,000 357,316 36,837,874
DEPRECIATION
Charge for period 1,281 22,639 28,376 52,296
At 31 March 2026 1,281 22,639 28,376 52,296
NET BOOK VALUE
At 31 March 2026 36,440,277 16,361 328,940 36,785,578
At 26 October 2025 751 - - 751

Cost or valuation at 31 March 2026 is represented by:

Fixtures
Short and Motor
leasehold fittings vehicles Totals
£    £    £    £   
Valuation in 2026 36,441,558 - - 36,441,558
Cost - 39,000 357,316 396,316
36,441,558 39,000 357,316 36,837,874

Fixed assets, included in the above, which are held under finance leases are as follows:
Short
leasehold
£   
COST OR VALUATION
Additions 35,892,394
Revaluations 540,937
At 31 March 2026 36,433,331
NET BOOK VALUE
At 31 March 2026 36,433,331

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


11. FIXED ASSET INVESTMENTS

Group
Unlisted
investments
£   
COST
At 27 October 2025
and 31 March 2026 1,571
NET BOOK VALUE
At 31 March 2026 1,571
At 26 October 2025 1,571
Company
Shares in
group
undertakings
£   
COST
Additions 40,200,015
At 31 March 2026 40,200,015
NET BOOK VALUE
At 31 March 2026 40,200,015

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

H Care Limited
Registered office: England and Wales
Nature of business: Holding company
%
Class of shares: holding
Ordinary direct 100.00
Ordinary indirect

Home From Home Care Limited
Registered office: England and Wales
Nature of business: Care home management
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


11. FIXED ASSET INVESTMENTS - continued

HFHC Specialist Supported Living Limited
Registered office: England and Wales
Nature of business: Labour recruitment and provision of personnel
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

HFHC Management Limited
Registered office: England and Wales
Nature of business: Care home management
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

HFHC Partnering Limited
Registered office: England and Wales
Nature of business: Provision of business premise
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

HFHC Properties Limited
Registered office: England and Wales
Nature of business: Dormant
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

Intersco (HFHC) Limited
Registered office: England and Wales
Nature of business: Provision of administration services
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00

Harkstave Healthcare Projects Limited
Registered office: England and Wales
Nature of business: Provision of building services
%
Class of shares: holding
Ordinary direct
Ordinary indirect 100.00


H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR


Group Company
£    £   
Trade debtors 2,179,643 -
Amounts owed by group undertakings - 166,751
Other debtors 3,096,185 -
Prepayments and accrued income 506,461 -
5,782,289 166,751

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR


Group Company
£    £   
Finance leases (see note 16) 650,352 -
Trade creditors 308,219 -
Amounts owed to group undertakings - 50
Taxation 122 -
Social security and other taxes 903,734 -
VAT 113,501 -
Other creditors 1,386,456 -
Wages and salaries 49,759 -
Accruals and deferred income 1,734,426 908,543
5,146,569 908,593

14. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR


Group Company
£    £   
Bank loans (see note 15) 8,700,000 8,700,000
Preference shares (see note 15) 28,213,834 28,213,834
Finance leases (see note 16) 20,706,697 -
57,620,531 36,913,834

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


15. LOANS

An analysis of the maturity of loans is given below:


Group Company
£    £   
Amounts falling due between two and five years:
Preference shares 28,213,834 28,213,834
Amounts falling due in more than five years:
Repayable by instalments
Bank loans 8,700,000 8,700,000

Details of shares shown as liabilities are as follows:

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
28,213,834 Preference £1 28,213,834

28,213,834 Preference shares of £1 each were allotted and fully paid for cash at par during the period.

16. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Finance
leases

£   
Net obligations repayable:
Within one year 650,352
Between one and five years 2,601,408
In more than five years 18,105,289
21,357,049

Group
Non-
cancellable
operating
leases
£   
Within one year 82,279
Between one and five years 47,595
129,874

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


17. PROVISIONS FOR LIABILITIES


Group
£   
Deferred tax 3,440,237

Group
Deferred
tax
£   
Liability acquired 3,305,003
Movement on revaluation 135,234
Balance at 31 March 2026 3,440,237

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100,000 Ordinary £1 100,000
3,686,166 Preference £1 3,686,166
3,786,166

The following shares were allotted and fully paid for cash at par during the period:

100,000 Ordinary shares of £1 each
3,686,166 Preference shares of £1 each

19. CONTINGENT LIABILITIES

There are fixed and floating charges over the assets of the group as security for a bank loan.

20. RELATED PARTY DISCLOSURES

The group has taken advantage of the exemption available in accordance with FRS 102 Section 33 'Related party disclosures' not to disclose transactions entered into between two or more members of a group, as the company and the other subsidiaries are wholly owned subsidiary undertakings of the group to which they are party to the transactions.

At the balance sheet date the group was owed £15,000 by another group owned and controlled by certain directors. During the period, £15,000 was recharged in relation to management fees.

During the period the group paid £32,605 to a director for consultancy services.

At the balance sheet date the group was also owed £2,966,913 by another group owned and controlled by two of the directors. Interest income of £210,508 was recognised on this balance during the period

During the period, a total of key management personnel compensation of £739,858 was paid.

H CARE 2025 LIMITED (REGISTERED NUMBER: 16811162)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 OCTOBER 2025 TO 31 MARCH 2026


21. ULTIMATE CONTROLLING PARTY

The controlling party is H J de Savary.

22. BUSINESS COMBINATION

On 25 November 2025, the group acquired 100% of the issued share capital of H Care Limited, whose principal activity is a holding company. The acquisition has been accounted for using the purchase method. From the acquisition date, the results and net assets of the acquired business have been included in the consolidated financial statements.

The total consideration was £40,200,015.

23. PREFERENCE SHARES

The group has two classes of £1 preference shares in issue. The rights attached to each class are summarised below. The legal class names and detailed terms should be agreed to the articles of association and the relevant share agreements.
Class Number Nominal value Classification
£
A Preference shares 28,213,834 28,213,834 Financial liability
B Preference shares 3,686,166 3,686,166 Equity

Liability-classified preference shares
The A Preference shares have been classified as a financial liability because their contractual terms require the company to pay a non-discretionary return of 8%. The shares are initially recognised at fair value, net of directly attributable transaction costs, and are subsequently measured at amortised cost.

The principal terms of this class are: nominal value of £1 per share; cumulative return of 8%; return payable annually; redemption at the holder’s option for £1 in respect of each preference share; each share shall receive one vote and capital will be distributed on a pro rata basis between the A and B shareholders. At 31 March 2026, the carrying amount recognised within creditors was £28,213,834. Finance costs of £779,166 were recognised in the period, of which nil was paid and £779,166 was accrued or added to the carrying amount.

Equity-classified preference shares
The B Preference shares have been classified as equity because the company has no contractual obligation to redeem the shares for cash or to make a non-discretionary payment to the holders. Distributions on these shares are recognised directly in equity when declared.

The principal terms of this class are: nominal value of £1 per share; no fixed redemption date;each share shall receive one vote and capital will be distributed on a pro rata basis between the A and B shareholders. At 31 March 2026, the aggregate nominal value included within called-up share capital was £3,686,166. No dividends were declared or paid during the period.